Enhancing immunotherapy with tumour-responsive nanomaterials.

Saved in:
Bibliographic Details
Title: Enhancing immunotherapy with tumour-responsive nanomaterials.
Authors: Linderman SW; Department of Mechanical Engineering, Massachusetts Institute of Technology, Cambridge, MA, USA.; Division of Hospital Medicine, Beth Israel Deaconess Medical Center, Boston, MA, USA., DeRidder L; David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA, USA.; Harvard-MIT Division of Health Science Technology, Massachusetts Institute of Technology, Cambridge, MA, USA., Sanjurjo L; Health Research Institute of Santiago de Compostela (IDIS), Santiago de Compostela, Spain.; Center for Research in Molecular Medicine and Chronic Diseases (CIMUS), University of Santiago de Compostela, Santiago de Compostela, Spain., Foote MB; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Alonso MJ; Center for Research in Molecular Medicine and Chronic Diseases (CIMUS), University of Santiago de Compostela, Santiago de Compostela, Spain.; Department of Pharmacy and Pharmaceutical Technology, University of Santiago de Compostela, Santiago de Compostela, Spain.; IMDEA Nanosciences Institute, Madrid, Spain., Kirtane AR; Department of Pharmaceutics, University of Minnesota, Minneapolis, MN, USA., Langer R; Department of Mechanical Engineering, Massachusetts Institute of Technology, Cambridge, MA, USA. rlanger@mit.edu.; David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA, USA. rlanger@mit.edu., Traverso G; Department of Mechanical Engineering, Massachusetts Institute of Technology, Cambridge, MA, USA. cgt20@mit.edu.; David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA, USA. cgt20@mit.edu.; Division of Gastroenterology, Hepatology and Endoscopy, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA. cgt20@mit.edu.; Broad Institute of MIT and Harvard, Cambridge, MA, USA. cgt20@mit.edu.
Source: Nature reviews. Clinical oncology [Nat Rev Clin Oncol] 2025 Apr; Vol. 22 (4), pp. 262-282. Date of Electronic Publication: 2025 Mar 06.
Publication Type: Journal Article; Review
Journal Info: Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101500077 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1759-4782 (Electronic) Linking ISSN: 17594774 NLM ISO Abbreviation: Nat Rev Clin Oncol Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1759-4782
DOI:10.1038/s41571-025-01000-6